Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 1 of 1 entries
View as:
Phase: N/A
Priority: Normal
Start: 08/08/22
End: 07/24/24
Due: 07/24/25
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Study of KBA1412 in Participants With Advanced Solid Malignant Tumors | NCT05501821 | Kling Biotherapeutics B.V. | user2@example.com | None | 2022-08-08 | 2024-07-24 | 2025-07-24 | - | - | 2025-07-14 |